2023
Unlocking the Proteome - The NULISA™ Platform
Entrant
Halteres Associates
Category
Video, Commercial & Film - Technology / Science
Client's Name
Alamar Biosciences
Country / Region
United States
Unlocking the Proteome -The NULISA™ Platform sets a new standard in proteomic analysis with attomolar sensitivity, allowing for unprecedented biomarker detection and quantitation.
By leveraging a proprietary sequential immunocomplex capture and release mechanism and the latest advances in Next Generation Sequencing (NGS), the NULISA technology provides both ultra-high sensitivity and scalable multiplexing.
Credits
Entrant
Myovant Sciences
Category
Strategic Program - Healthcare Campaign
Country / Region
United States
Entrant
ProPharma Group
Category
Provider & Services - Professional Services
Country / Region
United States
Entrant
Halteres Associates
Category
Video, Commercial & Film - Public Service & Activism
Country / Region
United States
Entrant
Innovation Protocol
Category
Website - Health Care Services
Country / Region
United States